Recombinant Lucilia cuprina FMRFamide-5

What is Recombinant Lucilia cuprina FMRFamide-5 and how is it classified?

Recombinant Lucilia cuprina FMRFamide-5 (LucFMRFamide-5) is a neuropeptide belonging to the FMRFamide-like peptide (FLP) family. It is a neuroactive peptide that resembles the tetrapeptide FMRFamide, which was originally isolated from the clam Macrocallista nimbosa . This specific peptide is derived from the Australian sheep blowfly (Lucilia cuprina) and has been produced as a recombinant protein expressed in E. coli . The peptide consists of nine amino acids with the sequence SPTQDFMRF, terminating with the characteristic RFamide motif that defines this peptide family .

What is the molecular structure and key properties of LucFMRFamide-5?

LucFMRFamide-5 is a nine-amino acid peptide with the sequence SPTQDFMRF . The peptide contains the characteristic C-terminal RFamide sequence that defines the FMRFamide-like peptide family. When produced as a recombinant protein, it typically achieves >85% purity as determined by SDS-PAGE analysis . The peptide represents the expression region 1-9 of the native protein and is synthesized using E. coli expression systems . Like other members of the FMRFamide family, it likely functions as a neuromodulator in signaling pathways, though its specific activities in Lucilia cuprina require further characterization in comparison to the well-studied FLPs from other species described in comprehensive reviews .

How does LucFMRFamide-5 compare structurally to other FMRFamide-like peptides across species?

LucFMRFamide-5 with its sequence SPTQDFMRF shares the characteristic C-terminal RFamide motif with other members of the FMRFamide family, but has a unique N-terminal extension (SPTQD) . This differs from classical FMRFamide peptides in other organisms. For example, in Cnidaria, FLPs typically contain the GRFa sequence at their C-terminus . In platyhelminths, common motifs include GYIRFa, YIRFa, and RYIRFa . Nematode FLPs display greater diversity with various N-terminal extensions followed by IRFa or MRFa motifs .

Structure-activity relationship studies have demonstrated that the C-terminal tetrapeptide is crucial for receptor binding and biological activity, with the N-terminal extensions modulating potency and selectivity . For instance, in platyhelminth FLPs, the YIRFa sequence is essential for potent activity, with the aromatic N-terminal amino acid being particularly important - substituting Y with F or W maintains activity but with different potencies (WIRFa showing EC50 of 0.1 nM compared to 100 nM for FIRFa) .

What are the recommended storage and handling conditions for Recombinant LucFMRFamide-5?

For optimal stability and activity of Recombinant Lucilia cuprina FMRFamide-5, the following storage and handling protocols are recommended:

• Storage temperature: Store at -20°C for regular use, or at -80°C for extended storage periods .

• Aliquoting: To prevent repeated freeze-thaw cycles, divide the stock solution into working aliquots. For short-term use (up to one week), working aliquots can be stored at 4°C .

• Reconstitution procedure:

  • Briefly centrifuge the vial before opening to bring contents to the bottom

  • Reconstitute the lyophilized peptide in deionized sterile water to a concentration of 0.1-1.0 mg/mL

  • For long-term storage, add glycerol to a final concentration of 5-50% (50% is the recommended standard)

  • Prepare small volume aliquots to minimize freeze-thaw cycles

• Shelf life: The stability varies depending on storage conditions:

  • Liquid form: Approximately 6 months at -20°C/-80°C

  • Lyophilized form: Approximately 12 months at -20°C/-80°C

Repeated freezing and thawing should be strictly avoided as it can significantly reduce peptide activity through degradation and structural changes to the amino acid sequence .

What experimental methods are suitable for studying LucFMRFamide-5 activity in neurological contexts?

To study LucFMRFamide-5 activity in neurological contexts, researchers can employ several experimental approaches based on methods used for related FMRFamide-like peptides:

• Electrophysiological recordings: Patch-clamp techniques can be used to measure the effects of LucFMRFamide-5 on membrane potential and ion channel activity in isolated neurons or neuronal cultures. This approach has been effective in studying FLP actions in various invertebrate species .

• Calcium imaging: Fluorescent calcium indicators can detect changes in intracellular calcium levels following LucFMRFamide-5 application, providing insights into receptor activation and downstream signaling pathways.

• Muscle contraction assays: Based on studies of other FLPs, isolated muscle fiber preparations can be used to assess LucFMRFamide-5's excitatory or inhibitory effects. For example, structure-activity studies on trematode isolated muscle fibers have been valuable in characterizing FLP activity, with EC50 values ranging from 1-7 nM for potent FLPs .

• Receptor binding studies: Radiolabeled or fluorescently tagged LucFMRFamide-5 can be used to identify receptor distribution and binding affinities. This approach should consider that FLP receptors typically belong to the G-protein coupled receptor (GPCR) family .

• Behavioral assays: In vivo applications of LucFMRFamide-5 followed by quantitative behavioral analysis can reveal functional roles in intact organisms. For example, in Cnidaria, certain FLPs influence planula larvae migration periods and activity levels .

For all these methods, appropriate controls including vehicle administration and structurally related peptides should be included for comparison.

How can researchers validate the activity and specificity of recombinant LucFMRFamide-5 preparations?

To validate the activity and specificity of recombinant LucFMRFamide-5 preparations, researchers should implement a multi-faceted approach:

• Analytical validation:

  • SDS-PAGE analysis to confirm purity (should be >85%)

  • Mass spectrometry to verify the correct molecular weight and sequence

  • HPLC analysis to assess purity and potential degradation products

  • Circular dichroism to examine secondary structure, especially if functional issues are suspected

• Functional validation:

  • Dose-response assays in established biological systems known to respond to FMRFamide-like peptides

  • Comparison with synthetic LucFMRFamide-5 or other well-characterized FLPs as positive controls

  • Analysis of specific cellular responses like calcium mobilization or cAMP production in receptor-expressing systems

• Specificity testing:

  • Competitive binding assays with known FLP receptor ligands

  • Testing structurally similar peptides with single amino acid substitutions to establish structure-activity relationships

  • Using receptor antagonists where available to block specific receptive pathways

• Cross-reactivity assessment:

  • Testing activity in heterologous systems expressing different FLP receptors

  • Immunological detection using antibodies specific to the FMRFamide epitope to confirm identity

These validation steps ensure that the observed biological effects are specifically attributed to LucFMRFamide-5 rather than contaminants or degradation products, which is critical for accurate interpretation of experimental results.

What is known about receptors that bind LucFMRFamide-5 and their signaling pathways?

While specific receptors for Lucilia cuprina FMRFamide-5 have not been fully characterized, insights can be drawn from studies of related FMRFamide-like peptide (FLP) receptors across invertebrate species:

FMRFamide receptors typically belong to the G-protein coupled receptor (GPCR) family. In platyhelminths, the first neuropeptide receptor (GtNPR-1) was identified in the turbellarian Girardia tigrina, showing 33% identity with the Caenorhabditis elegans receptor CeNPR-1 and 26% identity with the Drosophila receptor DM-sNPFR . This suggests evolutionary conservation of FLP receptor architecture that might extend to Lucilia cuprina.

For signaling pathways, studies in Fasciola hepatica provide evidence that the related peptide GYIRFamide mediates its excitatory effect through activation of phospholipase C, which stimulates production of diacylglycerol, which then promotes protein kinase C activity . This represents a likely signaling pathway for LucFMRFamide-5 as well.

In Hydra, certain RFamide peptides activate DEG/ENaC-like channels (HyNaC), suggesting ion channel modulation as another potential mechanism of action . The diversity of signaling pathways activated by FLPs across species indicates that LucFMRFamide-5 might employ multiple signaling mechanisms depending on the cellular context and receptor subtypes expressed.

Receptor-ligand studies in C. elegans have identified eight FLPs that activate specific receptors, with distinct selectivity profiles . By analogy, LucFMRFamide-5 likely acts on specific receptor subtypes with unique binding affinities and downstream effects.

How does the amino acid sequence of LucFMRFamide-5 influence its receptor binding properties?

The amino acid sequence of LucFMRFamide-5 (SPTQDFMRF) contains critical determinants that likely influence its receptor binding properties and biological activity. Based on structure-activity relationship studies of related FLPs, several key features can be identified:

• C-terminal RFamide motif: The RF-amide ending is essential for receptor recognition across the FLP family. Structure-activity studies in platyhelminths have shown that alterations to this motif render peptides inactive or drastically reduce potency .

• Phenylalanine (F) preceding the RF sequence: In the FMRF portion, the phenylalanine contributes significantly to binding affinity. Studies with platyhelminth FLPs demonstrated that having an aromatic amino acid at this position is important for receptor activation .

• Methionine (M) residue: The methionine in the FMRF sequence contributes to the hydrophobic interactions with receptor binding pockets. Structure-activity studies have shown that substituting hydrophobic amino acids like L, F, or M maintains activity, while less hydrophobic residues like V or A greatly reduce potency .

• N-terminal extension (SPTQD): While the C-terminal tetrapeptide is critical for receptor binding, the N-terminal extension likely modulates receptor selectivity and activation properties. These extensions often determine the potency differences between related FLPs. For example, in studies with isolated platyhelminth muscle fibers, different N-terminal extensions before the same C-terminal sequence resulted in EC50 values ranging from 29 nM to 1.69 μM .

The specific contribution of each amino acid in LucFMRFamide-5 would require dedicated structure-activity relationship studies, but these general principles from related FLPs provide a framework for understanding its likely binding properties.

What cross-reactivity might LucFMRFamide-5 have with receptors for other neuropeptides?

Based on studies of related FMRFamide-like peptides (FLPs), LucFMRFamide-5 may exhibit cross-reactivity with several neuropeptide receptor systems:

• Other FLP receptors: Given the conserved C-terminal RFamide motif, LucFMRFamide-5 might activate receptors for other FLPs across species with varying affinities. For instance, studies have shown that some nematode FLPs can activate flatworm muscle, demonstrating cross-phyla receptor activation. Notably, the nematode peptide PF4 (KPNFIRFa) activated Fasciola hepatica muscle with a threshold of 30 nM, while other nematode FLPs required 1-10 μM concentrations .

• RFamide peptide receptors: The broader family of RFamide-containing peptides shares the C-terminal motif, potentially enabling cross-reactivity. In Cnidaria, for example, various RFamide, RIamide, RNamide, RWamide, and RPamide peptides exist with specialized functions , suggesting diverse receptor subtypes that might respond to LucFMRFamide-5.

• Neuropeptide Y-related receptors: Some FLPs, particularly the NPF peptides with C-terminal GRPRFa, cross-react with pancreatic polypeptide (PP) antisera, a member of the vertebrate Neuropeptide Y superfamily . This suggests potential structural mimicry that could extend to receptor cross-activation.

• Species-specific considerations: The degree of cross-reactivity would vary significantly between species. For example, platyhelminth FLP receptors show preference for Y over F at the N-terminal, while mollusc receptors prefer F over Y , indicating species-specific receptor binding pockets that determine cross-reactivity profiles.

The extent of cross-reactivity would need to be experimentally determined through comparative receptor binding and activation studies across different neuropeptide systems and species.

What are the known physiological functions of FMRFamide-5 in Lucilia cuprina?

In invertebrates, FLPs are known to serve as important neuromodulators acting on various physiological systems including:

• Neuromuscular function: FLPs often regulate muscle contraction in invertebrates. For example, in platyhelminths, FLPs contract isolated muscle fibers with EC50 values in the nanomolar range . In Lucilia cuprina, FMRFamide-5 might similarly regulate body wall muscles, flight muscles, or visceral muscles involved in digestive and reproductive functions.

• Feeding behavior: Given that FLPs in other species modulate feeding circuits, LucFMRFamide-5 may participate in regulating feeding behaviors in the blowfly, which is particularly relevant given the species' role as a parasite of sheep.

• Reproductive physiology: FLPs have demonstrated roles in reproductive system regulation in various invertebrates. In platyhelminths, FLP immunoreactivity is present in nerve fibers innervating copulatory structures and genital tracts . LucFMRFamide-5 might have similar functions in L. cuprina reproductive physiology.

• Developmental processes: In some species like Cnidaria, certain neuropeptides regulate metamorphosis . Though not specifically established for L. cuprina, FMRFamide-5 could potentially modulate developmental transitions in this species.

• Sensory processing: FLP-containing fibers innervate sensory cells in some invertebrates , suggesting potential roles in sensory modulation that might extend to olfactory or gustatory processing in the blowfly.

These potential functions represent valuable starting points for targeted research into the specific roles of FMRFamide-5 in Lucilia cuprina physiology.

How can LucFMRFamide-5 be utilized in comparative neurobiology research?

LucFMRFamide-5 represents a valuable tool for comparative neurobiology research in several ways:

• Evolutionary conservation studies: By comparing the structure, expression patterns, and functions of LucFMRFamide-5 with FLPs from other species ranging from primitive invertebrates (Cnidaria) to more complex organisms, researchers can trace the evolutionary history of neuropeptide signaling. The FMRFamide family is ancient and widespread, making it an excellent model for studying the evolution of neuronal signaling systems .

• Receptor-ligand co-evolution: Examining how LucFMRFamide-5 interacts with receptors from different species can provide insights into the co-evolution of neuropeptides and their cognate receptors. For example, comparing its activity on Lucilia receptors versus those from other insects, nematodes, or platyhelminths can reveal evolutionary adaptations in receptor binding domains.

• Comparative physiology: Testing the effects of LucFMRFamide-5 across different species' physiological systems (e.g., muscle preparations, isolated neurons) can highlight convergent or divergent functions of FLP signaling. Previous studies have already shown that some FLPs can activate muscle contractions across phyla, though with different potencies .

• Neural circuit modulation: Using LucFMRFamide-5 as a probe to identify responsive neurons across species can reveal conserved or species-specific neuromodulatory circuits. This approach has been productive in Cnidaria, where approximately 40% of neurons in the hydrozoan planular nerve net are FLP-immunoreactive .

• Structure-activity relationship analysis: Comparing the activity of LucFMRFamide-5 and its fragments or analogs across species can provide insights into the structural basis of neuropeptide action and receptor selectivity. For instance, examining whether the SPTQDFMRF sequence has different potencies across species could reveal evolutionary specialization of receptor binding pockets.

These comparative approaches can significantly advance our understanding of the fundamental principles of neuronal communication and its evolution across animal phyla.

What potential applications exist for LucFMRFamide-5 in parasitology and pest control research?

LucFMRFamide-5 from Lucilia cuprina, an important livestock ectoparasite, presents several promising applications in parasitology and pest control research:

• Target validation for novel antiparasitic compounds: If LucFMRFamide-5 mediates essential physiological functions in L. cuprina, its receptors could represent valuable targets for selective pest control agents. By characterizing these receptors and their signaling pathways, researchers could develop antagonists that specifically disrupt blowfly physiology without affecting non-target organisms.

• Disruption of sensory perception: If LucFMRFamide-5 modulates sensory processing related to host-finding behaviors in L. cuprina, manipulating this pathway could interfere with the parasite's ability to locate hosts. This approach could lead to push-pull strategies where synthetic analogs either repel parasites from livestock or trap them in monitoring devices.

• Reproductive interference: Studies in platyhelminths have shown FLP involvement in reproductive system regulation . If LucFMRFamide-5 plays similar roles in L. cuprina reproduction, targeting its signaling could potentially reduce fertility or reproductive success, offering an alternative to conventional insecticides.

• Comparative vulnerability assessment: Testing the activity of LucFMRFamide-5 across beneficial and pest insects could identify species-specific responses that might be exploited for selective control. This is particularly valuable given concerns about the impact of broad-spectrum insecticides on pollinator populations.

• Biomarker development: LucFMRFamide-5 or its metabolites could potentially serve as biomarkers for L. cuprina infestation, enabling earlier detection and intervention before significant economic damage occurs.

• Understanding resistance mechanisms: As L. cuprina has developed resistance to multiple conventional insecticides, studying neuropeptide systems like FMRFamide-5 could reveal alternative physiological targets that bypass existing resistance mechanisms, extending the useful life of integrated pest management programs.

These applications highlight the potential translational value of basic research on LucFMRFamide-5 biology for addressing the economic impact of blowfly parasitism in livestock production.

What methodological challenges exist in studying the in vivo effects of LucFMRFamide-5?

Investigating the in vivo effects of LucFMRFamide-5 presents several methodological challenges that researchers must address:

• Peptide delivery and stability:

  • Neuropeptides typically have short half-lives in vivo due to proteolytic degradation

  • Delivering LucFMRFamide-5 to its target tissues in intact organisms requires overcoming various barriers

  • Methods such as microinjection, lipid encapsulation, or development of enzymatically resistant analogs may be necessary to maintain effective concentrations

• Tissue-specific targeting:

  • FMRFamide-like peptides often act on multiple tissues and cell types

  • Distinguishing primary from secondary effects requires strategies for localized delivery

  • Optogenetic or chemogenetic approaches adapted for Lucilia cuprina could provide temporal and spatial control of peptide activity

• Physiological readouts:

  • Identifying appropriate physiological parameters to measure responses to LucFMRFamide-5

  • Development of insect-specific assays that can detect subtle changes in neuronal activity, muscle contraction, or behavior

  • Correlation of molecular mechanisms (e.g., receptor activation) with whole-organism responses

• Genetic manipulation limitations:

  • The genetic toolkit for Lucilia cuprina is less developed compared to model organisms like Drosophila

  • Creating receptor knockouts or peptide overexpression models may require adapting CRISPR/Cas9 or RNAi techniques

  • Establishing stable transgenic lines for studying LucFMRFamide-5 function presents technical hurdles

• Compensatory mechanisms:

  • Redundancy in neuropeptide signaling systems may mask phenotypes when manipulating a single peptide

  • Other FLPs or neuropeptides might compensate for altered LucFMRFamide-5 signaling

  • Developing combinatorial approaches to target multiple components simultaneously may be necessary

Addressing these challenges requires innovative experimental designs that combine molecular, cellular, and behavioral approaches while accounting for the biological complexity of neuropeptide signaling networks.

What approaches can be used to identify the gene encoding LucFMRFamide-5 and study its expression patterns?

To identify the gene encoding LucFMRFamide-5 and characterize its expression patterns in Lucilia cuprina, researchers can employ a multi-faceted approach combining genomic, transcriptomic, and histological techniques:

• Genomic and transcriptomic approaches:

  • Genome mining: Using the known peptide sequence (SPTQDFMRF) to search the L. cuprina genome for coding regions

  • Degenerate PCR: Designing primers based on conserved regions of FLP genes across related insect species

  • RNA-Seq analysis: Examining transcriptome data from different tissues and developmental stages to identify transcripts containing the LucFMRFamide-5 sequence

  • RACE (Rapid Amplification of cDNA Ends): Once partial sequences are identified, this technique can be used to obtain full-length cDNA sequences

• Expression pattern analysis:

  • Quantitative RT-PCR: Measuring transcript levels across tissues, developmental stages, and under different physiological conditions

  • In situ hybridization: Localizing mRNA expression in tissue sections to identify specific cells producing the peptide

  • Immunohistochemistry: Using antibodies raised against LucFMRFamide-5 or the conserved FMRFamide epitope to localize the peptide in tissues

  • Mass spectrometry imaging: Mapping peptide distribution in tissue sections with high spatial resolution

• Regulatory element characterization:

  • Promoter analysis: Identifying regulatory regions controlling gene expression

  • Reporter gene constructs: Creating transgenic lines with fluorescent proteins driven by the native promoter to visualize expression patterns in vivo

  • ChIP-Seq: Identifying transcription factors binding to the promoter region

• Comparative analysis:

  • Examining expression patterns across closely related dipteran species

  • Comparing expression across different life stages (larvae, pupae, adults)

  • Contrasting expression between sexes to identify sex-specific roles

These approaches would provide comprehensive insight into the genetic basis of LucFMRFamide-5 production, its tissue distribution, developmental regulation, and potential functional specialization, establishing a foundation for targeted functional studies of this neuropeptide in Lucilia cuprina.

How does the sequence and structure of LucFMRFamide-5 compare with related peptides across species?

The following table provides a comparative analysis of LucFMRFamide-5 with structurally related FMRFamide-like peptides (FLPs) from various species:

This comparative analysis reveals several key insights:

• Conservation of RFamide motif: All these peptides share the C-terminal RFamide motif, though with variations in the amino acids preceding RF .

• Species-specific extensions: While maintaining the critical C-terminal region, different species have evolved unique N-terminal extensions that likely contribute to receptor selectivity and specific physiological functions .

• Phylogenetic patterns: Certain motifs show phylum-specific patterns - GRFamides in Cnidaria, IRFamides in platyhelminths and nematodes, and more diverse patterns in arthropods .

• Functional divergence: Despite structural similarities, these peptides can have dramatically different or even opposite effects depending on the species and tissue (e.g., inhibitory versus excitatory actions on muscle) .

LucFMRFamide-5 with its SPTQDFMRF sequence represents a unique member of this peptide family, with the FMRF core matching the canonical tetrapeptide first discovered in molluscs, but with an N-terminal extension specific to Lucilia cuprina.

What experimental systems and assays have been used to study FMRFamide-like peptides across different species?

The following table summarizes key experimental systems and assays that have been employed to study FMRFamide-like peptides across various species, which can be adapted for research on Lucilia cuprina FMRFamide-5:

This diverse array of experimental approaches highlights several important considerations for researchers studying LucFMRFamide-5:

• Multi-level analysis: Comprehensive understanding requires examining effects from molecular (receptor binding) to behavioral levels.

• Comparative approach: Testing LucFMRFamide-5 in systems established for other FLPs allows direct comparison of potency and efficacy.

• System selection: The choice of experimental system should align with the specific research question, whether focused on neuromuscular effects, sensory modulation, or developmental roles.

• Technical adaptations: Many of these methods would require specific adjustments for application to Lucilia cuprina, particularly the development of appropriate tissue preparations and physiological readouts.

• Integration of approaches: Combining multiple experimental systems provides the most robust evidence for physiological functions and mechanisms of action.

What structure-activity relationships have been established for FMRFamide-like peptides that might apply to LucFMRFamide-5?

Based on extensive structure-activity relationship studies of FMRFamide-like peptides across various species, the following table summarizes key findings that likely apply to understanding LucFMRFamide-5 activity:

These structure-activity relationships provide several important insights for LucFMRFamide-5 research:

• Critical determinants: The RF-amide ending and hydrophobic residues in the tetrapeptide core are likely essential for LucFMRFamide-5 activity, with modifications to these regions potentially abolishing function.

• Modifiable regions: The N-terminal extension (SPTQD) could be modified to create analogs with altered potency, selectivity, or stability while maintaining core activity.

• Predictive value: Based on these patterns, LucFMRFamide-5 would be expected to show moderate to high potency at its cognate receptors, with activity likely in the nanomolar range.

• Design principles for analogs: Researchers developing LucFMRFamide-5 analogs could incorporate aromatic substitutions at position 6 (replacing F with W) to potentially enhance potency, or add N-terminal pyroglutamate to improve stability.

• Species selectivity: The unique N-terminal extension of LucFMRFamide-5 likely contributes to species-specific receptor activation patterns that distinguish its activity from related FLPs in other organisms.